Pfizer and BioNTech will receive $2 billion from the U.S. government for 100 million doses of their coronavirus vaccine— if it is proven as safe for human consumption and effective in the prevention of the virus. The government also has the ability to acquire an additional 500 million doses of the drug going forward. As of yet, only preliminary research has been announced. In order to prove effective, the companies will have to conduct large-scale international trials. As a trusted clinical packaging provider and clinical supplies premium courier, as well as ancillary materials provider backed by a strong global network, Yourway can support clinical trials wherever they occur.